pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Aug 26·1 min read
save

UCSF maps over 1,800 protein interactions linked to autism, revealing new drug target opportunities

Aug 26, 2026·read at Fierce Biotech ↗Positive

UCSF scientists created a molecular map of autism by analyzing 100 risk genes, which uncovered more than 1,800 protein-protein interactions.

The study found that about 87% of these connections had not been reported before, indicating a large amount of previously unknown biology.

Researchers used AlphaFold, an AI tool that predicts protein structures, to focus on direct interactions and identified highly interconnected cell hubs that converge on shared pathways.

The authors say the map offers a blueprint for drug discovery, pointing to potential druggable targets for autism, especially the most severe, non-verbal forms.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Research into protein interactions sheds new light on causes of autism”

read at Fierce Biotech ↗
518 words · retrieved Aug 27
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
University of California San Francisco2ELI LILLY COEli Lilly and CoInSilico MedicineLILLYMonte Rosa Therapeutics, Inc.NOVARTISWM TECHNOLOGY, INC.
drugs
Small Molecules
topics
Molecular Glue2Oncology

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Jun 12STAT+: Prometheus raises $12 billion in capital for artificial engineersSTAT
  • Jun 11STAT+: Abridge inks deals with Nvidia and LillySTAT
  • Dec 23Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40%Fierce Biotech
  • 19h agoCaribou layoffs could wipe out 90% of staffBioSpace